Dragpharma

Species

Dogs and cats.

Description

Choleretic, cytoprotective and immunomodulatory.

Dosage form

Oral suspension

Therapeutic action

Choleretic, cytoprotective and immunomodulatory.

Composition

Each 1 mL of oral suspension contains:
Ursodeoxycholic acid ................ 50 mg
Excipients c.s.p. ........................ 1 mL

Indications

Ursovet® oral suspension is indicated for the treatment of inflammatory hepatobiliary diseases that occur with hepatobiliary cholestasis, in dogs and cats. Due to its choleretic, cytoprotective and immunomodulatory properties, its use is useful in cases of chronic hepatitis, cholangitis, cholangiohepatitis and cases of cholestasis that do not present with biliary obstruction.

Route od administration and dosage

Administration way: Oral.

Dose of the active principle in dogs and cats: 10 to 15 mg / Kg, every 24 hours or divided every 12 hours.

Product dosage:

• Dogs: 2 to 3 mL for every 10 kg of body weight, every 24 hours or divided every 12 hours.
• Cats: 0.2 to 0.3 mL for each Kg of body weight, every 24 hours or divided every 12 hours.

It is recommended that treatment be administered for 3 to 4 months after the patient has presented improvement in the biochemical markers for liver disease.

Drug interactions

Antacids containing Aluminum or Cholestyramine resin can bind Ursodeoxycholic Acid reducing its effectiveness.

Contraindications

• Do not use in patients with biliary obstruction, fistula, pancreatitis or other complication associated with cholelithiasis.
• Do not use in patients with known hypersensitivity to bile acids.
• Do not use in rabbits or other colonic fermenting species. In these species, Ursodeoxycholic acid is converted to lithocholic acid (toxic).
• Special caution should be exercised in patients with chronic liver disease, as they may have greater difficulty in metabolizing bile acids.
• Do not use in pregnant females or during the lactation period.

Special precautions for use

Wash your hands after administering the product.

Warnings

Keep out of the reach of children.

Adverse effects

• In rare cases, there may be episodes of vomiting and / or diarrhea. In this case, discontinue use and consult your Veterinarian.
• Faced with overdose, it is recommended to perform a gastric emptying, or the administration of activated carbon or an antacid containing aluminum.

Observations

Shake before using.

Special precautions for disposal of unused product or waste material:
Discard any unused product remains in its original container. Do not throw the empty container or with product remains, in rivers, lakes or streams of water. Do not reuse the container. Dispose of the waste of this product where possible, in suitable places where special waste is disposed of.

Conservation

Store at room temperature, between 15 ° and 30 ° C.
Once opened, use the product within 3 months. Discard the unused product after that period of time.

Condition of sale

Sale with veterinary prescription.

Presentation

60 mL bottle

Prepared by

Laboratorio Drag Pharma Chile Invetec S.A.

Records

Chile: Reg. SAG N° 2034
Costa Rica: Reg. N° MAG CL 4-48-12-6133
Uruguay: Reg. MGAP: 2018A00569
Perú: Registro SENASA F.G7.02.I.0001

Countries where it is marketed

Imported in Uruguay by VIVAFIL S.A.
RIO NEGRO 1107 Montevideo - Uruguay,
TEL 29001112
grupotecnovet@gmail.com
Technical Director: DMTV Diego Cuadrado.

Imported and Distributed in Peru by Representaciones Durand SAC.
Av. Manuel Olguín No. 501 Office No. 604 Santiago de Surco Lima.

Imported and distributed in Bolivia by:
ZOOFARMA
TEL: +(591)222-3357
Street Díaz Romero 1339, La Paz.